Effects of Monoamine Reuptake Inhibitor NS2330 in Parkinson's Disease

NCT00006077 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

50

Enrollment

NIH

Sponsor class

Conditions

Parkinson's Disease

Interventions

DRUG: NS2330
DRUG: Levodopa and Domperidone

Sponsor

National Institute of Neurological Disorders and Stroke (NINDS)